Advertisement
Screener

Harrow, Inc. (HROW) Debt Instrument, Decrease, Forgiveness

2.8 / 5 stars · 68/120 Roast Me

Harrow, Inc. Debt Instrument, Decrease, Forgiveness

Harrow, Inc. (HROW) reported Debt Instrument, Decrease, Forgiveness of -$176.50 thousand for the 188-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.

Discontinued › Notes › Debt › Debt Instruments › Debt Instrument, Increase (Decrease), Net

us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2014-05-15

  • Harrow, Inc. debt instrument, decrease, forgiveness for the quarter ending 2013-03-31 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for the quarter ending 2012-03-31 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for the quarter ending 2011-12-31 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for the quarter ending 2011-09-30 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for fiscal 2012 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for fiscal 2011 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for fiscal 2010 was $0.00.
  • Harrow, Inc. debt instrument, decrease, forgiveness for fiscal 2007 was $241.70K.
Period endDebt Instrument, Decrease, Forgiveness 3 monthDebt Instrument, Decrease, Forgiveness 6 monthDebt Instrument, Decrease, Forgiveness 9 monthDebt Instrument, Decrease, Forgiveness 12 monthDebt Instrument, Decrease, Forgiveness 155 monthDebt Instrument, Decrease, Forgiveness 158 monthDebt Instrument, Decrease, Forgiveness 161 monthDebt Instrument, Decrease, Forgiveness 164 monthDebt Instrument, Decrease, Forgiveness 167 monthDebt Instrument, Decrease, Forgiveness 170 monthDebt Instrument, Decrease, Forgiveness 173 monthDebt Instrument, Decrease, Forgiveness 176 monthDebt Instrument, Decrease, Forgiveness 182 monthDebt Instrument, Decrease, Forgiveness 185 monthDebt Instrument, Decrease, Forgiveness 188 month
2014-03-31-$176.50K
10-Q · filed 2014-05-15
2013-12-31-$176.50K
10-K · filed 2014-03-28
2013-09-30-$176.50K
10-Q · filed 2013-11-06
2013-06-30$241.70K
10-Q · filed 2013-08-14
2013-03-31$0.00
10-Q · filed 2013-05-08
$241.70K
10-Q · filed 2013-05-08
2012-12-31$0.00
10-K · filed 2013-03-18
$241.70K
10-K · filed 2013-03-18
2012-09-30$241.70K
10-Q · filed 2012-11-14
2012-06-30$241.70K
10-Q · filed 2012-08-14
2012-03-31$0.00
10-Q · filed 2013-05-08
$0.00
derived: sum of 2 quarters · filed 2013-05-08
$0.00
derived: sum of 3 quarters · filed 2013-05-08
$0.00
derived: sum of 4 quarters · filed 2013-05-08
$241.70K
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$0.00
derived: sum of 2 quarters · filed 2013-03-18
$0.00
derived: sum of 3 quarters · filed 2013-03-18
$0.00
10-K · filed 2013-03-18
$241.70K
10-K · filed 2012-02-23
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23
$0.00
derived: sum of 2 quarters · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
$0.00
derived: sum of 4 quarters · filed 2012-05-10
$241.70K
10-Q · filed 2012-02-23
2011-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
$0.00
derived: sum of 3 quarters · filed 2012-05-10
$0.00
derived: sum of 4 quarters · filed 2012-05-10
$241.70K
10-Q · filed 2012-02-23
2011-03-31$0.00
10-Q · filed 2012-05-10
$0.00
derived: sum of 2 quarters · filed 2012-05-10
$0.00
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
$0.00
derived: sum of 2 quarters · filed 2012-02-23
$0.00
10-K · filed 2012-02-23
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
2010-06-30$0.00
10-Q · filed 2012-02-23
2007-12-31$241.70K
10-K · filed 2014-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B